Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-03-18 | Mr. Michael B. MoorePresident | -136,80k | 1,24M | Verkauf | 8,77 - 9,42 | 1,77M | -7,16% |
| 2026-03-18 | Mr. Michael B. MoorePresident | -136,80k | 1,24M | Verkauf | 8,77 - 9,42 | 1,77M | -7,16% |
| 2026-01-29 | Mr. Casey HoytCEO & Director | 39,80k | 0,00 | Derivative Exercise and Retained Stock | - | 2,34M | 1,73% |
| 2026-01-29 | Mr. Casey HoytCEO & Director | -13,27k | 99,22k | Derivative Exercise and Sale | 7,48 | 2,34M | - |
| 2026-01-29 | Mr. Casey HoytCEO & Director | -13,91k | 104,07k | Sale to Issuer | 7,48 | 2,34M | -0,59% |
| 2026-01-29 | Mr. William Todd ZehnderCOO & Director | 26,84k | 0,00 | Derivative Exercise and Retained Stock | - | 390,31k | 7,38% |
| 2026-01-29 | Mr. William Todd ZehnderCOO & Director | -8,95k | 66,93k | Derivative Exercise and Sale | 7,48 | 390,31k | - |
| 2026-01-29 | Mr. William Todd ZehnderCOO & Director | -11,37k | 85,03k | Sale to Issuer | 7,48 | 390,31k | -2,83% |
| 2026-01-29 | Mr. Trae Paul FitzgeraldCFO | 9,79k | 0,00 | Derivative Exercise and Retained Stock | - | 105,64k | 10,22% |
| 2026-01-29 | Mr. Trae Paul FitzgeraldCFO | -3,27k | 24,42k | Derivative Exercise and Sale | 7,48 | 105,64k | - |
| 2026-01-29 | Mr. Trae Paul FitzgeraldCFO | -2,68k | 20,04k | Sale to Issuer | 7,48 | 105,64k | -2,47% |
| 2026-01-29 | Dr. William Dana FrazierChief Medical Officer & Director | 2,33k | 0,00 | Derivative Exercise and Retained Stock | - | 73,21k | 3,29% |
| 2026-01-29 | Dr. William Dana FrazierChief Medical Officer & Director | -778,00 | 5,82k | Derivative Exercise and Sale | 7,48 | 73,21k | - |
| 2026-01-29 | Dr. William Dana FrazierChief Medical Officer & Director | -802,00 | 6,00k | Sale to Issuer | 7,48 | 73,21k | -1,08% |
| 2026-01-29 | Mr. Jerome Richard CambreVP of Sales | 8,62k | 0,00 | Derivative Exercise and Retained Stock | - | 104,09k | 9,03% |
| 2026-01-29 | Mr. Jerome Richard CambreVP of Sales | -2,87k | 21,49k | Derivative Exercise and Sale | 7,48 | 104,09k | - |
| 2026-01-29 | Mr. Jerome Richard CambreVP of Sales | -2,36k | 17,62k | Sale to Issuer | 7,48 | 104,09k | -2,21% |
| 2026-01-29 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | 10,77k | 0,00 | Derivative Exercise and Retained Stock | - | 46,49k | 30,16% |
| 2026-01-29 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -3,59k | 26,86k | Derivative Exercise and Sale | 7,48 | 46,49k | - |
| 2026-01-29 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -2,94k | 21,98k | Sale to Issuer | 7,48 | 46,49k | -5,95% |
| 2026-01-29 | Mr. Michael B. MoorePresident | 26,84k | 0,00 | Derivative Exercise and Retained Stock | - | 1,91M | 1,42% |
| 2026-01-29 | Mr. Michael B. MoorePresident | -8,95k | 66,92k | Derivative Exercise and Sale | 7,48 | 1,91M | - |
| 2026-01-29 | Mr. Michael B. MoorePresident | -7,34k | 54,92k | Sale to Issuer | 7,48 | 1,91M | -0,38% |
| 2026-01-21 | Mr. William Todd ZehnderCOO & Director | 117,55k | 0,00 | Derivative Exercise and Retained Stock | - | 374,84k | 45,69% |
| 2026-01-21 | Mr. William Todd ZehnderCOO & Director | -8,55k | 64,07k | Derivative Exercise and Sale | 7,49 | 374,84k | - |
| 2026-01-21 | Mr. William Todd ZehnderCOO & Director | -35,08k | 262,71k | Sale to Issuer | 7,49 | 374,84k | -8,56% |
| 2026-01-21 | Mr. Trae Paul FitzgeraldCFO | 13,32k | 0,00 | Derivative Exercise and Retained Stock | - | 98,52k | 15,63% |
| 2026-01-21 | Mr. Trae Paul FitzgeraldCFO | -3,33k | 24,93k | Derivative Exercise and Sale | 7,49 | 98,52k | - |
| 2026-01-21 | Mr. Trae Paul FitzgeraldCFO | -4,25k | 31,80k | Sale to Issuer | 7,49 | 98,52k | -4,13% |
| 2026-01-21 | Mr. Jerome Richard CambreVP of Sales | 11,72k | 0,00 | Derivative Exercise and Retained Stock | - | 97,82k | 13,61% |
| 2026-01-21 | Mr. Jerome Richard CambreVP of Sales | -2,93k | 21,95k | Derivative Exercise and Sale | 7,49 | 97,82k | - |
| 2026-01-21 | Mr. Jerome Richard CambreVP of Sales | -3,83k | 28,66k | Sale to Issuer | 7,49 | 97,82k | -3,76% |
| 2026-01-21 | Dr. William Dana FrazierChief Medical Officer & Director | 3,40k | 0,00 | Derivative Exercise and Retained Stock | - | 71,68k | 4,98% |
| 2026-01-21 | Dr. William Dana FrazierChief Medical Officer & Director | -850,00 | 6,37k | Derivative Exercise and Sale | 7,49 | 71,68k | - |
| 2026-01-21 | Dr. William Dana FrazierChief Medical Officer & Director | -1,17k | 8,76k | Sale to Issuer | 7,49 | 71,68k | -1,60% |
| 2026-01-21 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | 14,65k | 0,00 | Derivative Exercise and Retained Stock | - | 38,66k | 61,01% |
| 2026-01-21 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -3,66k | 27,43k | Derivative Exercise and Sale | 7,49 | 38,66k | - |
| 2026-01-21 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -4,78k | 35,82k | Sale to Issuer | 7,49 | 38,66k | -11,01% |
| 2026-01-21 | Mr. Michael B. MoorePresident | -9,36k | 70,09k | Sale to Issuer | 7,49 | 1,89M | -0,49% |
| 2026-01-21 | Mr. Michael B. MoorePresident | 34,21k | 0,00 | Derivative Exercise and Retained Stock | - | 1,89M | 1,84% |
| 2026-01-21 | Mr. Michael B. MoorePresident | -8,55k | 64,07k | Derivative Exercise and Sale | 7,49 | 1,89M | - |
| 2026-01-21 | Mr. Casey HoytCEO & Director | 49,60k | 0,00 | Derivative Exercise and Retained Stock | - | 2,31M | 2,19% |
| 2026-01-21 | Mr. Casey HoytCEO & Director | -12,40k | 92,88k | Derivative Exercise and Sale | 7,49 | 2,31M | - |
| 2026-01-21 | Mr. Casey HoytCEO & Director | -13,57k | 101,60k | Sale to Issuer | 7,49 | 2,31M | -0,58% |
| 2026-01-17 | Mr. Michael B. MoorePresident | 26,94k | 0,00 | Derivative Exercise and Retained Stock | - | 1,87M | 1,46% |
| 2026-01-17 | Mr. Michael B. MoorePresident | -6,74k | 49,37k | Derivative Exercise and Sale | 7,33 | 1,87M | - |
| 2026-01-17 | Mr. Michael B. MoorePresident | -8,55k | 62,66k | Sale to Issuer | 7,33 | 1,87M | -0,46% |
| 2026-01-17 | Mr. Casey HoytCEO & Director | 40,07k | 0,00 | Derivative Exercise and Retained Stock | - | 2,27M | 1,79% |
| 2026-01-17 | Mr. Casey HoytCEO & Director | -10,02k | 73,42k | Derivative Exercise and Sale | 7,33 | 2,27M | - |
| 2026-01-17 | Mr. Casey HoytCEO & Director | -12,12k | 88,82k | Sale to Issuer | 7,33 | 2,27M | -0,53% |
| 2026-01-17 | Mr. William Todd ZehnderCOO & Director | 26,94k | 0,00 | Derivative Exercise and Retained Stock | - | 292,36k | 10,15% |
| 2026-01-17 | Mr. William Todd ZehnderCOO & Director | -6,74k | 49,37k | Derivative Exercise and Sale | 7,33 | 292,36k | - |
| 2026-01-17 | Mr. William Todd ZehnderCOO & Director | -8,55k | 62,67k | Sale to Issuer | 7,33 | 292,36k | -2,84% |
| 2026-01-17 | Mr. Trae Paul FitzgeraldCFO | 9,59k | 0,00 | Derivative Exercise and Retained Stock | - | 89,45k | 12,01% |
| 2026-01-17 | Mr. Trae Paul FitzgeraldCFO | -2,40k | 17,57k | Derivative Exercise and Sale | 7,33 | 89,45k | - |
| 2026-01-17 | Mr. Trae Paul FitzgeraldCFO | -3,13k | 22,96k | Sale to Issuer | 7,33 | 89,45k | -3,38% |
| 2026-01-17 | Mr. Jerome Richard CambreVP of Sales | 8,53k | 0,00 | Derivative Exercise and Retained Stock | - | 89,93k | 10,47% |
| 2026-01-17 | Mr. Jerome Richard CambreVP of Sales | -2,13k | 15,63k | Derivative Exercise and Sale | 7,33 | 89,93k | - |
| 2026-01-17 | Mr. Jerome Richard CambreVP of Sales | -2,78k | 20,41k | Sale to Issuer | 7,33 | 89,93k | -3,00% |
| 2026-01-17 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | 4,88k | 0,00 | Derivative Exercise and Retained Stock | - | 28,79k | 20,43% |
| 2026-01-17 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -1,22k | 8,95k | Derivative Exercise and Sale | 7,33 | 28,79k | - |
| 2026-01-17 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -1,60k | 11,69k | Sale to Issuer | 7,33 | 28,79k | -5,25% |
| 2025-08-22 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | 5,97k | 0,00 | Derivative Exercise and Retained Stock | - | 25,50k | 30,57% |
| 2025-08-22 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -2,99k | 21,83k | Derivative Exercise and Sale | 7,31 | 25,50k | - |
| 2025-08-22 | Mr. Jeremy TrahanGeneral Counsel & Corporate Secretary | -1,63k | 11,94k | Sale to Issuer | 7,31 | 25,50k | -6,02% |
| 2025-08-20 | Mr. Nitin KaushalIndependent Director | 15,73k | 0,00 | Derivative Exercise and Retained Stock | - | 142,58k | 12,40% |
| 2025-08-20 | Mr. Timothy SmokoffIndependent Director | 15,73k | 0,00 | Derivative Exercise and Retained Stock | - | 95,52k | 19,72% |
| 2025-08-20 | Mr. Randolph E. DobbsIndependent Chairman | 17,78k | 0,00 | Derivative Exercise and Retained Stock | - | 125,49k | 16,51% |
| 2025-08-20 | Ms. Sabrina HeltzIndependent Director | 15,73k | 0,00 | Derivative Exercise and Retained Stock | - | 67,49k | 30,39% |
| 2025-08-13 | Mr. Jerome Richard CambreVP of Sales | -4,88k | 35,74k | Verkauf | 7,32 - 7,33 | 84,19k | -5,48% |
| 2025-08-12 | Mr. Michael B. MoorePresident | -50,09k | 367,16k | Verkauf | 7,33 | 1,85M | -2,64% |
| 2025-01-29 | Mr. Michael B. MoorePresident | -8,95k | 74,09k | Sale to Issuer | 8,28 | 1,90M | -0,47% |
| 2025-06-27 | Mr. Michael B. MoorePresident | -181,32k | 809,51k | Derivative Exercise and Sale | 1,81 - 7,00 | 1,90M | - |
| 2025-06-30 | Mr. Nitin KaushalIndependent Director | -7,05k | 1,97k | Derivative Exercise and Sale | 6,63 - 6,91 | 126,84k | - |
| 2025-06-26 | Mr. Nitin KaushalIndependent Director | -42,95k | 16,23k | Derivative Exercise and Sale | 6,63 - 7,01 | 126,84k | - |
| 2025-06-26 | Mr. Nitin KaushalIndependent Director | -42,95k | 16,23k | Derivative Exercise and Sale | 6,63 - 7,01 | 126,84k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
